Science Current Events | Science News | Brightsurf.com
 

Researchers discover how to overcome poor response to radiotherapy caused by low haemoglobin levels

May 11, 2012
Results from a randomized trial in head and neck cancer

Barcelona, Spain: Patients with head and neck cancer and a low haemoglobin (Hb) level do not respond well to radiotherapy and therefore both control of their tumour and disease-free survival are compromised. Now researchers from The Netherlands have found that the problems caused by low Hb in these patients can be overcome by the use of a treatment known as ARCON therapy, in which accelerated radiotherapy is combined with carbogen (a mixture of carbon dioxide and oxygen) and the water-soluble vitamin nicotinamide [1].

Hans Kaanders, a professor of translational radiation oncology at Radboud University Nijmegen Medical Centre, Nijmegen, will tell the 31st conference of the European Society for Radiotherapy and Oncology [2] today (Friday) that the ARCON regime is the first to show a positive effect in patients with low Hb levels.

The researchers recruited 345 patients with squamous cell laryngeal cancer to a randomised trial: 174 received only accelerated radiotherapy (where two fractions per day are administered during the last week of radiotherapy in order to reduce the overall length of treatment), and 171 ARCON. Patients receiving ARCON inhaled carbogen during radiotherapy and took nicotinamide tablets prior to treatment. Pre-treatment Hb levels in the experimental group were measured and subsequently compared with the treatment outcomes in the accelerated radiotherapy alone arm.

They found that patients treated with accelerated radiotherapy alone who had normal Hb levels before treatment had significantly better control of the cancer at its primary site (76% as opposed to 56%), disease-free survival (72% and 48% respectively), and metastasis-free survival (90% and 70%) than those with low Hb levels.

"However, when we looked at the ARCON group, in cases where the patients had low Hb levels before treatment, we found that ARCON improved control of the cancer at its primary site, and improved disease-free and metastasis-free survival, so that the differences between them and patients with normal Hb levels were no longer significant," says Professor Kaanders' colleague Dr. Geert Janssens. The difference in local control between this low Hb group and the normal Hb accelerated radiotherapy (AR) alone group was only 1% (81% in the ARCON group versus 82% in the AR-only group); for disease-free survival, the difference was 77% (ARCON) as opposed to 70% (AR); and for metastasis-free survival 93% (ARCON) versus 89% (AR).

However, patients in both groups with low Hb levels pre-treatment still had a worse overall survival irrespective of which treatment they received. This is most likely due the fact that many patients with head and neck cancer also have other health problems that cannot be treated by radiotherapy, the researchers say.

"In the past, a number of investigators have tried to improve the outcome for patients with low Hb levels by giving erythropoietin, which stimulates red blood cell production, and red cell blood transfusion before and during treatment, but without success. ARCON is the first treatment to be found to correct for low Hb and therefore to improve prognosis in these patients," says Dr. Janssens. "We know that a decrease in Hb levels is associated with a reduced sensitivity to radiotherapy, and that this can switch the tumour microenvironment into a more aggressive subtype with a higher risk of loco-regional failure and of the development of distant metastases."

The lack of success with transfusion of red blood cells or erythropoietin suggests underlying adaptive mechanisms. Accelerated radiotherapy to counteract tumour cell repopulation during radiotherapy, combined with carbogen and nicotinamide, administered immediately before irradiation to increase the oxygen level, ensures that adaptive mechanisms cannot erode the effect, and this is probably the key to success of the ARCON regime in patients with low HB levels at presentation, the researchers say.

"We believe that, at a time when healthcare systems are under increasing pressure to introduce expensive targeted treatments, the use of such a low cost, effective therapy should only be encouraged," Professor Kaanders will conclude.

Prof Vincenzo Valentini, radiation oncologist at the Policlinico Universitario A. Gemelli in Rome, Italy, and President of ESTRO, said: "We know that the degree of oxygenation of tumours in laryngeal cancer patients is directly related to the damage that can be caused to them by radiotherapy. This important study shows that, in patients with low haemoglobin levels, it is possible to reoxygenate the tumour by using the simple and cost-effective ARCON regime, and therefore increase the effectiveness of radiation treatment."

###

Abstract no: OC 217, 10.30 hrs, Friday 11 May, Auditorium

[1] When carbogen is inhaled, the increased level of carbon dioxide causes the brain to react to potential suffocation because it interprets the increase in blood carbon dioxide as a decrease in oxygen level, and the body compensates by reducing hypoxia. Nicotinamide also reduces hypoxia by increasing blood flow.

[2] This year the ESTRO conference is held in parallel with the World Congress of Brachytherapy, both taking place in Barcelona from May 9-13.

European Society for Radiotherapy and Oncology (ESTRO)


Related Radiotherapy Current Events and Radiotherapy News Articles


The past, present and future of pancreatic cancer research and treatment
The oncologists Manuel Hidalgo, Director of the Clinical Research Programme of the Spanish National Cancer Research Centre (CNIO), and Ignacio Garrido-Laguna, member of the Experimental Therapeutics Program at Huntsman Cancer Institute of the University of Utah (USA), have recently published a review of state-of-the-art clinical treatments for pancreatic cancer -- including the most current therapies and innovative research -- in the prestigious scientific journal Nature Reviews Clinical Oncology.

MD Anderson study points to potential new lung cancer therapy
New findings about regulation of PD-L1, a protein that allows cancer to evade the immune system, has shown therapeutic promise for several cancers, including the most common form of lung cancer.

Use of radiotherapy after prostate cancer surgery declining, despite evidence of benefit
Despite strong evidence and guidelines supporting its use, post-surgical radiation therapy for prostate cancer patients at risk of recurrence is declining in the United States. The study, published online in the journal European Urology, finds fewer than 10 percent of patients at risk of recurrence received postoperative radiotherapy within six months of surgery in the U.S.

A common nerve protein elevated in aggressive neuroblastomas
A protein produced by nerve cells appears to be elevated in the blood of those with an aggressive form of neuroblastoma.

Red Journal's May issue focuses on the vital role of RT in modern lymphoma treatment
The "Radiation and the Modern Management of Lymphoma" issue (May 1, 2015) of the International Journal of Radiation Oncology * Biology * Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO), is focused on the integral role of radiation therapy in current lymphoma treatment.

Protein finding can pave the way for improved treatment of malignant melanoma
Today it is not possible to predict spreading from malignant melanomas. Melanoma metastases are furthermore extremely difficult to eliminate as traditional treatment such as chemotherapy and radiotherapy is mostly ineffective.

Potential for prediction of progression for early form of breast cancer
Scientists in Manchester have identified a way to potentially predict which patients with an early form of breast cancer will experience disease progression.

New breath technology picks up high risk changes heralding stomach cancer
A new type of technology that senses minute changes in the levels of particular compounds in exhaled breath, accurately identifies high risk changes which herald the development of stomach cancer, reveals research published online in the journal Gut.

York scientists lead study on new treatment for prostate cancer
Scientists at the University of York have discovered a potential new treatment for prostate cancer using low temperature plasmas (LTPs).

Physicians pioneer the use of stereotactic body radiation for deadly kidney cancer complication
UT Southwestern Medical Center Kidney Cancer Program investigators have published what is believed to be the first reported successful use of stereotactic body radiation therapy for an often deadly complication of kidney cancer.
More Radiotherapy Current Events and Radiotherapy News Articles

Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy (Medical Radiology)

Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy (Medical Radiology)
by Nancy Y. Lee (Editor), Nadeem Riaz (Editor), Jiade J. Lu (Editor)


This textbook is designed to help the busy radiation oncologist to accurately and confidently delineate tumor volumes for conformal radiation therapy (including IMRT). The book provides an atlas of clinical target volumes (CTVs) for commonly encountered cancers, with each chapter illustrating CTV delineation on a slice-by-slice basis, on planning CT images. Common anatomic variants for each tumor are represented in individual illustrations, with annotations highlighting differences in coverage. The anatomy of each site and patterns of lymphatic drainage are discussed, and their influence on the design of CTVs is explained in detail. Utilization of other imaging modalities, including MRI, to delineate volumes is highlighted. Key details of simulation and planning are briefly reviewed....

Basic Radiotherapy Physics and Biology

Basic Radiotherapy Physics and Biology
by David S. Chang (Author), Foster D. Lasley (Author), Indra J. Das (Author), Marc S. Mendonca (Author), Joseph R. Dynlacht (Author)


This book is a concise and well-illustrated review of the physics and biology of radiation therapy intended for radiation oncology residents, radiation therapists, dosimetrists, and physicists. It presents topics that are included on the Radiation Therapy Physics and Biology examinations and is designed with the intent of presenting information in an easily digestible format with maximum retention in mind. The inclusion of mnemonics, rules of thumb, and reader-friendly illustrations throughout the book help to make difficult concepts easier to grasp. Basic Radiotherapy Physics and Biology is a valuable reference for students and prospective students in every discipline of radiation oncology.

Radiation Oncology - A Question Based Review 2nd Edition

Radiation Oncology - A Question Based Review 2nd Edition
by Borislav Hristov (Editor), Steven H. Lin MD PhD (Editor), John P. Christodouleas MD MPH (Editor)


Test and solidify your knowledge of radiation oncology with Radiation Oncology: A Question-Based Review. This book’s Q&A format doesn’t merely encourage rote memorization, but expounds on most answers’ reasoning, background information, and clinical context to foster your complete understanding. Written by top experts, with each chapter authored by at least one resident and one faculty member, Radiation Oncology: A Question-Based Review is the perfect learning tool for students and physicians who are seeking to strengthen their long-term command of radiation oncology.

FEATURESCovers all sites and cancer types currently treated with radiotherapy with an emphasis on treatment recommendations and the evidence behind them.Detailed questions on the natural history,...

Stereotactic Body Radiotherapy: A Practical Guide

Stereotactic Body Radiotherapy: A Practical Guide
by Andrew Gaya (Editor), Anand Mahadevan (Editor)


This is a single, comprehensive handbook for clinical oncology trainees and consultants, covering the basic aspects of stereotactic radiotherapy systems and treatment.

Clinical Radiation Oncology, 4e

Clinical Radiation Oncology, 4e
by Leonard L. Gunderson MD MS FASTRO (Author), Joel E. Tepper MD (Author)


Perfect for radiation oncology physicians and residents needing a multidisciplinary, treatment-focused resource, this updated edition continues to provide the latest knowledge in this consistently growing field. Not only will you broaden your understanding of the basic biology of disease processes, you'll also access updated treatment algorithms, information on techniques, and state-of-the-art modalities. The consistent and concise format provides just the right amount of information, making Clinical Radiation Oncology a welcome resource for use by the entire radiation oncology team.Content is templated and divided into three sections -- Scientific Foundations of Radiation Oncology, Techniques and Modalities, and Disease Sites - for quick access to information. Disease Sites chapters...

Khan's The Physics of Radiation Therapy

Khan's The Physics of Radiation Therapy
by Faiz M. Khan PhD (Author), John P. Gibbons PhD (Author)


Expand your understanding of the physics and practical clinical applications of advanced radiation therapy technologies with Khan's The Physics of Radiation Therapy, 5th edition, the book that set the standard in the field. This classic full-color text helps the entire radiation therapy team—radiation oncologists, medical physicists, dosimetrists, and radiation therapists—develop a thorough understanding of 3D conformal radiotherapy (3D-CRT), stereotactic radiosurgery (SRS), high dose-rate remote afterloaders (HDR), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), Volumetric Modulated Arc Therapy (VMAT), and proton beam therapy, as well as the physical concepts underlying treatment planning, treatment delivery, and dosimetry.

In preparing...

The Physics of Radiotherapy X-Rays And Electrons

The Physics of Radiotherapy X-Rays And Electrons
by Peter Metcalfe (Author), Tomas Kron (Author), Peter Hoban (Author)


The Physics of Radiotherapy X-Rays and Electrons is an updated successor to The Physics of Radiotherapy X-Rays from Linear Accelerators published in 1997. This new volume includes a significant amount of new material, including new chapters on electrons in radiotherapy and IMRT, IGRT, and tomotherapy, which have become key developments in radiation therapy.

Also updated from the earlier edition are the physics beam modeling chapters, including Monte Carlo methods, adding those mysterious electrons, as well as discourse on radiobiological modeling including TCP, NTCP, and EUD and the impact of these concepts on plan analysis and inverse planning.

This book is intended as a standard reference text for postgraduate radiation oncology medical physics students. It will also be of...

Treatment Planning in Radiation Oncology

Treatment Planning in Radiation Oncology
by Faiz M Khan PhD (Author), Bruce J. Gerbi PhD (Author)


Updated specifically for the latest in sophisticated radiation oncology treatment modalities, the Third Edition of Treatment Planning in Radiation Oncology provides a comprehensive discussion of the clinical, physical, and technical aspects of treatment planning.

Handbook of Treatment Planning in Radiation Oncology, Second Edition

Handbook of Treatment Planning in Radiation Oncology, Second Edition
by Gregory Videtic MD CM FRCPC (Editor), Neil Woody MD (Editor)


This is a highly practical resource about the specific technical aspects of delivering radiation treatment. Pocket-sized and well organized for ease of use, the book is designed to lead radiation oncology trainees and residents step by step through the basics of radiotherapy planning and delivery for all major malignancies. This new, evidence-based edition retains the valued, practical features of the first edition while incorporating recent advances in the field. Chapters are the result of a joint collaboration between residents and staff radiation oncologists in the Department of Radiation Oncology at the Cleveland Clinic. Sections are organized by body site or system―whichever is best suited to consistency in presenting planning principles. Also included are such specialized topics...

Radiotherapy Treatment Planning: Linear-Quadratic Radiobiology

Radiotherapy Treatment Planning: Linear-Quadratic Radiobiology
by J. Donald Chapman (Author), Alan E. Nahum (Author)


Understand Quantitative Radiobiology from a Radiation Biophysics Perspective In the field of radiobiology, the linear-quadratic (LQ) equation has become the standard for defining radiation-induced cell killing. Radiotherapy Treatment Planning: Linear-Quadratic Radiobiology describes tumor cell inactivation from a radiation physics perspective and offers appropriate LQ parameters for modeling tumor and normal tissue responses. Explore the Latest Cell Killing Numbers for Defining Iso-Effective Cancer Treatments The book compiles radiation mechanism information from biophysical publications of the past 50 years, addressing how ionizing radiation produces the killing of stem cells in human tumors. It presents several physical and chemical parameters that can modulate the radiation response...

© 2015 BrightSurf.com